Ibex Wealth Advisors Sells 183,825 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Ibex Wealth Advisors decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 97.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 3,961 shares of the company's stock after selling 183,825 shares during the quarter. Ibex Wealth Advisors' holdings in GE HealthCare Technologies were worth $310,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. D1 Capital Partners L.P. acquired a new position in GE HealthCare Technologies during the 3rd quarter worth approximately $268,159,000. Van ECK Associates Corp bought a new position in shares of GE HealthCare Technologies in the 3rd quarter worth $208,513,000. State Street Corp grew its position in GE HealthCare Technologies by 7.8% in the 3rd quarter. State Street Corp now owns 18,615,890 shares of the company's stock valued at $1,747,101,000 after purchasing an additional 1,347,114 shares during the period. Massachusetts Financial Services Co. MA bought a new stake in GE HealthCare Technologies during the 3rd quarter valued at $93,713,000. Finally, Geode Capital Management LLC raised its holdings in GE HealthCare Technologies by 7.2% during the third quarter. Geode Capital Management LLC now owns 10,977,757 shares of the company's stock worth $1,026,898,000 after buying an additional 733,819 shares during the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Analysts Set New Price Targets

GEHC has been the topic of several recent research reports. Jefferies Financial Group raised shares of GE HealthCare Technologies from a "hold" rating to a "buy" rating and raised their price target for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. Wells Fargo & Company raised their target price on GE HealthCare Technologies from $95.00 to $96.00 and gave the company an "overweight" rating in a report on Thursday, October 31st. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus price target of $96.00.

GE HealthCare Technologies Stock Performance

GEHC traded up $1.55 during trading hours on Thursday, hitting $89.40. The stock had a trading volume of 464,331 shares, compared to its average volume of 2,688,506. The stock has a market cap of $40.84 billion, a PE ratio of 24.56, a price-to-earnings-growth ratio of 2.88 and a beta of 1.11. GE HealthCare Technologies Inc. has a 1 year low of $72.52 and a 1 year high of $94.55. The company has a quick ratio of 0.98, a current ratio of 1.23 and a debt-to-equity ratio of 1.12. The company's fifty day simple moving average is $82.61 and its 200 day simple moving average is $84.92.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.14 EPS for the quarter, beating analysts' consensus estimates of $1.06 by $0.08. GE HealthCare Technologies had a net margin of 8.56% and a return on equity of 25.19%. The company had revenue of $4.86 billion for the quarter, compared to analysts' expectations of $4.87 billion. During the same period in the prior year, the company posted $0.99 EPS. GE HealthCare Technologies's revenue was up .9% compared to the same quarter last year. Equities analysts anticipate that GE HealthCare Technologies Inc. will post 4.3 earnings per share for the current year.

GE HealthCare Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 14th will be given a $0.035 dividend. This is a positive change from GE HealthCare Technologies's previous quarterly dividend of $0.03. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.16%. The ex-dividend date of this dividend is Tuesday, January 14th. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.85%.

Insider Activity at GE HealthCare Technologies

In related news, CEO Roland Rott sold 3,577 shares of the business's stock in a transaction dated Wednesday, November 6th. The stock was sold at an average price of $86.48, for a total transaction of $309,338.96. Following the completion of the transaction, the chief executive officer now directly owns 24,298 shares in the company, valued at $2,101,291.04. The trade was a 12.83 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is owned by corporate insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.